uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board
London, UK – October 19, 2018
uMotif building an advisory group of world-leading experts to make patient-centric clinical research a reality
uMotif are pleased to announce they are working with Willie Muehlhausen as their special advisor for electronic Clinical Outcomes Assessments and Patient Reported Outcomes (eCOA and ePRO) as the first member of a multi-disciplinary advisory board to ensure patients are put at the centre of clinical research.
“Working with Willie will provide uMotif with industry leading expertise for eCOA, ePRO and Bring Your Own Device (BYOD) approaches that work at scale and deliver the validated output needed by clinical researchers. This will enable us to ensure our platform continues to deliver the best data for our customers while providing an industry leading patient experience.” said Bruce Hellman, uMotif CEO and co-founder.
Previously with ICON, ERT, PAREXEL and the ePRO consortium, Muehlhausen has been working with patient reported outcomes for over 20 years. Since 2009 he has spearheaded the move to bring your own device (BYOD) data collection and the benefits this approach brings the entire research ecosystem.
Muehlhausen said “I believe the successful eCOA providers of the future will combine high-quality and validated data capture with a patient-first engagement led approach all underpinned by modern technology. I’m delighted to be working with organisations like uMotif who are taking this approach. It’s good for researchers, healthcare professionals and, most of all, patients and participants ”
uMotif is the leading modern data capture platform for research, that patients love to use. With industry leading expertise in Real World and non-interventional studies, the engaging and clinically-proven platform captures e-consent, eCOA / ePRO, symptom and wearable device data. Working with top pharma, CROs and e-clinical platforms, uMotif can be deployed quickly across the world in any condition.
About Muehlhausen Ltd After more than 20 years as successful serial intrapreneur, delivering innovative solutions to the clinical trial industry, Willie started a Consulting business in August 2018 to support clinical trial technologists, CROs, biopharmaceutical companies and venture capital organisations to deliver best technology to patients. For the last few years his research focus has been on Innovation/Crowdsourcing and BYOD in the context of Patient-Centric Clinical Trials.
For more on uMotif visit www.umotif.com
Connect with uMotif on LinkedIn
Follow uMotif on twitter: @uMotif
Connect with Willie Muehlhausen on LinkedIn: LinkedIn
Follow Muehlhausen Ltd on twitter: @wmepro